title: Should measures be taken to reduce the risk of human parvovirus (B19) infection by transfusion of blood components and clotting factor concentrates?
authors.forename: J W
authors.initials: JW
authors.lastname: Mosley
mesh_terms: D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D016913:Blood Component Transfusion; D016731:Erythema Infectiosum / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D016732:Parvovirus B19, Human / Q000302:isolation & purification
chemical_list: D001779:Blood Coagulation Factors